2019
DOI: 10.1093/eurheartj/ehz330
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable vs. permanent polymer drug-eluting stents: the need for a new nomenclature to classify drug-eluting stent technology

Abstract: Abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 14 publications
(12 reference statements)
0
2
0
Order By: Relevance
“…The most used DD schemes comprise polymer reservoir-based structures, pumps (peristaltic, infusion, and osmotic), and micro and nano electromechanical structures (MEMS and NEMS), see e.g., [79][80][81][82][83][84][85][86][87][88][89][90][91][92][93][94]. Reservoir structures utilize drug release by dispersion via a film structure.…”
Section: Implantable Drug Delivery Schemesmentioning
confidence: 99%
“…The most used DD schemes comprise polymer reservoir-based structures, pumps (peristaltic, infusion, and osmotic), and micro and nano electromechanical structures (MEMS and NEMS), see e.g., [79][80][81][82][83][84][85][86][87][88][89][90][91][92][93][94]. Reservoir structures utilize drug release by dispersion via a film structure.…”
Section: Implantable Drug Delivery Schemesmentioning
confidence: 99%
“…Although the diameter of plastic stents is small, it is easy to get restenosis due to biliary mud deposition in a very short time. 9,10 Thus, plastic stents often need to be replaced repeatedly under endoscopy, which is not only painful but also expensive and risky. 11,12 To deal with such issues, it is crucial to prevent the deposition of biliary mud in stents and prolong the patency time of plastic stents as much as possible.…”
Section: Introductionmentioning
confidence: 99%
“…Phenotypic switching can also underpin the pathogenesis of atherosclerosis, aortic aneurysm formation and hypertension [6,7,8]. While drug-eluting stents, and more recently, biodegradable drug-eluting stents, have improved clinical outcomes following PCI [9,10], challenges such as in-stent SMC hyperplasia, inadequate re-endothelialization and thrombosis remain [11,12]. Hence, a better understanding of molecular control in injured blood vessels and effective translation of this knowledge into the clinical arena is needed.…”
Section: Introductionmentioning
confidence: 99%